According to Coherent Market
Insights, The Global Alprostadil Injection Market is estimated to be valued
at USD 212.4 Mn in 2025 and is expected to reach USD 347.8
Mn by 2032, exhibiting a compound annual growth rate (CAGR)
of 7.3% from 2025 to 2032. Emerging market trends highlight an
increasing shift toward minimally invasive therapies and personalized drug
delivery solutions. Advances in formulation and administration technologies,
including enhanced injection methods and combination therapies, are driving
improved patient adherence and better clinical outcomes

Request Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/8403

Global Alprostadil Injection Market
Key Takeaways

According to Coherent Market Insights
(CMI), The Global Alprostadil Injection Market is estimated to be valued
at USD 212.4 Mn in 2025 and is expected to reach USD 347.8
Mn by 2032, exhibiting a compound annual growth rate (CAGR)
of 7.3% from 2025 to 2032.

Intracavernosal injection is expected
to remain the top-selling product type, accounting for more than three-fifths
of the global market revenue share in 2025.

Based on strength, 10 mcg segment is
set to account for 23.2% of the global Alprostadil injection market share by
2025.

Erectile dysfunction is expected to
remain the most lucrative application of Alprostadil injection, accounting for
95.5% of the market share in 2025.

North America, with an estimated
share of 37.3% in 2025, is set to dominate the global Alprostadil injection
industry.

Asia Pacific is poised to become the
most lucrative market for Alprostadil injection manufacturers during the
assessment period.

Immediate Delivery Available | Buy This Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/8403

Rising Incidence of Erectile Dysfunction Spurring Market Growth

Coherent Market Insights’ latest Alprostadil
injection market analysis outlines key factors driving industry growth. One
such prominent growth driver is the increasing incidence of erectile
dysfunction (ED).

According to Johns Hopkins Medicine, about
322 million men worldwide are expected to have erectile dysfunction in 2025.
This rising prevalence is expected to boost demand for effective treatments
like Alprostadil injections during the forecast period.

Alprostadil injection has become a
highly sought-after treatment for erectile dysfunction (ED). For instance,
CMI’s analysis indicates that around 95% of Alprostadil injections will be used
for treating erectile dysfunction in 2025. Higher the cases of ED, greater will
be Alprostadil injection demand.

Also Read: Erectile Dysfunction Treatment Market
Size, Share, Trends & Opportunities for 2025-2032

High Treatment Costs and Alternatives
Limiting Market Growth

Despite a positive Alprostadil
injection market outlook, certain factors are expected to slow down growth.
These include high cost of Alprostadil injections and increasing adoption of
alternative treatments.

Alprostadil injections are quite
expensive. Edex (Alprostadil) 20 mcg, for instance, typically costs around
$230.07. This limits accessibility for a significant portion of patient
population, dampening Alprostadil injection market demand.

In addition, many people are opting
for alternative ED treatments like Sildenafil and topical creams due to their
low cost and less invasive nature. This may slow down Alprostadil injection
market growth, especially in underserved regions.

Growing Sexual Health Awareness
Creating Growth Prospects

Increasing awareness of sexual health
is reducing stigma and fostering more open discussions about conditions such as
erectile dysfunction. This shift encourages more individuals to seek medical
advice as well as treatment, potentially driving demand and growth
opportunities for Alprostadil injection manufacturers.

Emerging Alprostadil Injection Market Trends

Increasing acceptance of Alprostadil injections due to their
quick action as well as high efficacy is a key growth-shaping trend. Patients
with ED who do not respond to oral ED medications often opt for Alprostadil
injections.

Expanding applications of Alprostadil injection beyond
erectile dysfunction are providing a big market push. Alprostadil is gaining
traction in neonatal care, especially for maintaining the patency of the ductus
arteriosus in newborns with congenital heart defects. Rising number of babies
diagnosed with conditions like Patent Ductus Arteriosus (PDA) will likely propel
demand for Alprostadil injections.

Innovations like auto-injectors and pre-filled syringes make
administering injections easier for patients. They cut down on complicated
preparation, so patients are more likely to stick to their treatment.

Rising geriatric population is likely to uplift Alprostadil
injections during the forecast period. Older people are prone to conditions
such as ED, which increases the need for treatments like Alprostadil
injections.

Also Read: Erectile Dysfunction
Devices Market Outlook for 2025-2032

Analyst’s
View

“The global Alprostadil injection industry is set to expand
steadily, owing to rising prevalence of erectile dysfunction, growing demand
for effective ED treatments, increasing sexual health awareness, and
advancements in injection technologies,” said a senior CMI analyst.

Current Events and Their Impact on the Alprostadil
Injection Market

Event

Description
and Impact

Rising Prevalence of Erectile Dysfunction (ED)

  • Description: Recent
    epidemiological studies indicate a sharp rise in ED cases among men aged
    40 to 70, partly due to lifestyle diseases (diabetes, obesity,
    cardiovascular conditions).

Impact: This
will likely fuel demand for alprostadil injections, especially in regions
with aging populations like North America as well as Western Europe.

Regulatory Support

  • Description: FDA and EMA have recently updated guidance on
    ED drug trials and introduced expedited review processes for therapies
    targeting high-unmet needs.
  • Impact: This has
    helped new Alprostadil products (like extended-release or combination
    versions) reach the market faster, enabling faster revenue generation as
    well as competitive advantage.

Innovation in Penile Injection Devices

  • Description: New
    auto-injectors and less invasive delivery systems are being launched.
  • Impact: These innovations lead to higher patient adherence and broader
    market penetration, particularly among patients hesitant about
    traditional injections.

 

Competitor Insights

Key companies in the Alprostadil
injection market report:

–       Viatris Inc.

–       Pfizer Inc.

–       Hikma Pharmaceuticals

–       Endo Inc.

–       Meitheal Pharmaceuticals

–       Other Prominent Players

Key Developments

In March 2025, Meitheal Pharmaceuticals
launched a new Alprostadil Injection, USP 500 mcg/ml in vial form. This new
launch will help the company address the ongoing product shortages.

Get Customization on this Report: https://www.coherentmarketinsights.com/insight/request-customization/8403

Market Segmentation

  • Product Type Insights (Revenue,
    USD Mn, 2020 – 2032)
    • Intracavernosal Injection
    • Intraurethral Injection
  • Strength Insights (Revenue, USD
    Mn, 2020 – 2032)
    • 10 mcg
    • 20 mcg
    • 40 mcg
    • 250 mcg
    • 500 mcg
    • 1,000 mcg
  • Application Insights (Revenue, USD Mn, 2020 –
    2032)
    • Erectile Dysfunction (ED)
    • Patent Ductus Arteriosus
      (Palliative Therapy)
  • End User Insights (Revenue, USD Mn, 2020 –
    2032)
    • Hospitals
    • Clinics
    • Urological Centers
    • Home Healthcare
    • Others (Academic and Research
      Institutions, etc.)
  • Distribution Channel Insights
    (Revenue, USD Mn, 2020 – 2032)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Regional Insights (Revenue, USD
    Mn, 2020 – 2032)
    • North America
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa

Also Read: Palliative Care Market
Analysis & Forecast for 2025-2032

Our Trusted Partners:

Worldwide Market Reports, Coherent MI, Stratagem Market Insights

Get Recent News:

https://www.coherentmarketinsights.com/news

About Us:
Coherent Market Insights leads into data and analytics, audience
measurement, consumer behaviors, and market trend analysis. From shorter
dispatch to in-depth insights, CMI has exceled in offering research, analytics,
and consumer-focused shifts for nearly a decade. With cutting-edge syndicated
tools and custom-made research services, we empower businesses to move in the
direction of growth. We are multifunctional in our work scope and have 450+
seasoned consultants, analysts, and researchers across 26+ industries spread
out in 32+ countries.